Terminal Value

Orphazyme A/S (ORPH)

$ 4.51
-0.06 -1.31%
Growth in perpetuity method:
Long-term growth rate
WACC (%) 6.56
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Now that we’ve estimated the free cash flow generated over the five-year forecast period, we need to estimate the value of Orphazyme A/S’s cash flows after that period (if we don’t include this, we would have to assume that Orphazyme A/S stopped operating at the end of the five-year forecast period). To do so, we’ll determine the company’s terminal value.